annual operating expenses:
$1.02B+$61.23M(+6.39%)Summary
- As of today (July 6, 2025), RARE annual total operating expenses is $1.02 billion, with the most recent change of +$61.23 million (+6.39%) on December 31, 2024.
- During the last 3 years, RARE annual operating expenses has risen by +$302.34 million (+42.16%).
- RARE annual operating expenses is now at all-time high.
Performance
RARE Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$253.57M-$16.69M(-6.18%)Summary
- As of today (July 6, 2025), RARE quarterly total operating expenses is $253.57 million, with the most recent change of -$16.69 million (-6.18%) on March 31, 2025.
- Over the past year, RARE quarterly operating expenses has dropped by -$3.08 million (-1.20%).
- RARE quarterly operating expenses is now -17.44% below its all-time high of $307.14 million, reached on September 30, 2022.
Performance
RARE quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
RARE Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.4% | -1.2% |
| 3 y3 years | +42.2% | +20.5% |
| 5 y5 years | +96.5% | +58.0% |
RARE Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +42.2% | -17.4% | +13.9% |
| 5 y | 5-year | at high | +96.5% | -17.4% | +106.2% |
| alltime | all time | at high | >+9999.0% | -17.4% | +5320.5% |
RARE Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $253.57M(-6.2%) |
| Dec 2024 | $1.02B(+6.4%) | $270.26M(+7.9%) |
| Sep 2024 | - | $250.46M(+3.5%) |
| Jun 2024 | - | $242.11M(-5.7%) |
| Mar 2024 | - | $256.65M(+8.1%) |
| Dec 2023 | $958.25M(-2.6%) | $237.39M(+2.3%) |
| Sep 2023 | - | $232.16M(-5.8%) |
| Jun 2023 | - | $246.35M(+1.7%) |
| Mar 2023 | - | $242.34M(-0.5%) |
| Dec 2022 | $983.93M(+37.2%) | $243.66M(-20.7%) |
| Sep 2022 | - | $307.14M(+37.9%) |
| Jun 2022 | - | $222.67M(+5.8%) |
| Mar 2022 | - | $210.47M(+15.4%) |
| Dec 2021 | $717.13M(+20.5%) | $182.44M(+9.1%) |
| Sep 2021 | - | $167.30M(+0.4%) |
| Jun 2021 | - | $166.62M(-17.0%) |
| Mar 2021 | - | $200.78M(+10.2%) |
| Dec 2020 | $595.02M(+14.7%) | $182.14M(+40.7%) |
| Sep 2020 | - | $129.44M(+5.3%) |
| Jun 2020 | - | $122.96M(-23.4%) |
| Mar 2020 | - | $160.48M(+28.4%) |
| Dec 2019 | $518.88M(+23.0%) | $124.94M(-11.5%) |
| Sep 2019 | - | $141.15M(+3.9%) |
| Jun 2019 | - | $135.86M(+16.2%) |
| Mar 2019 | - | $116.93M(+10.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $421.72M(+27.2%) | $106.09M(+4.9%) |
| Sep 2018 | - | $101.14M(-6.0%) |
| Jun 2018 | - | $107.55M(+0.6%) |
| Mar 2018 | - | $106.94M(+7.8%) |
| Dec 2017 | $331.55M(+33.6%) | $99.25M(+18.3%) |
| Sep 2017 | - | $83.91M(+7.0%) |
| Jun 2017 | - | $78.44M(+12.1%) |
| Mar 2017 | - | $69.95M(-0.9%) |
| Dec 2016 | $248.14M(+68.0%) | $70.55M(+7.1%) |
| Sep 2016 | - | $65.89M(+13.5%) |
| Jun 2016 | - | $58.07M(+8.3%) |
| Mar 2016 | - | $53.62M(-4.5%) |
| Dec 2015 | $147.74M(+160.2%) | $56.16M(+40.6%) |
| Sep 2015 | - | $39.94M(+32.5%) |
| Jun 2015 | - | $30.14M(+40.2%) |
| Mar 2015 | - | $21.50M(+26.9%) |
| Dec 2014 | $56.78M(+75.9%) | $16.94M(+7.0%) |
| Sep 2014 | - | $15.84M(+15.9%) |
| Jun 2014 | - | $13.66M(+32.1%) |
| Mar 2014 | - | $10.34M(+8.5%) |
| Dec 2013 | $32.28M(+101.9%) | $9.53M(+22.7%) |
| Sep 2013 | - | $7.76M(-5.9%) |
| Jun 2013 | - | $8.25M(+22.2%) |
| Mar 2013 | - | $6.75M(+44.2%) |
| Dec 2012 | $15.98M(+143.6%) | $4.68M |
| Dec 2011 | $6.56M | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual total operating expenses?
- What is the all time high annual operating expenses for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual operating expenses year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly operating expenses year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual total operating expenses?
The current annual operating expenses of RARE is $1.02B
What is the all time high annual operating expenses for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual total operating expenses is $1.02B
What is Ultragenyx Pharmaceutical Inc. annual operating expenses year-on-year change?
Over the past year, RARE annual total operating expenses has changed by +$61.23M (+6.39%)
What is Ultragenyx Pharmaceutical Inc. quarterly total operating expenses?
The current quarterly operating expenses of RARE is $253.57M
What is the all time high quarterly operating expenses for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly total operating expenses is $307.14M
What is Ultragenyx Pharmaceutical Inc. quarterly operating expenses year-on-year change?
Over the past year, RARE quarterly total operating expenses has changed by -$3.08M (-1.20%)